Answers are grounded in this paper and cite their sources.
Clinical evaluation of etomidate, an ultrashortacting nonbarbiturate hypnotic agent, shows it to be useful for anesthetic induction in adults. It produces sleep in 1 arm-brain circulation time, metabolites apparently peaking at 7 minutes postinjection. Cardiovascular and respiratory systems appear minimally affected and there is no indication of organ toxicity or other biochemical or hematologic drug-induced disturbances. Moderate pain on injection at some sites and transient myoclonia were the principal disadvantages observed.
No takes yet. Share an insight, caveat, or question.
Gooding et al. (1976) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: